The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Nanoparticles in cancer therapy and diagnosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Research works printed but not linked: 23
- Krishna, 2000, Multidrug resistance (MDR) in cancer—mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, Eur. J. Cancer Sci., 11, 265
- Brasseur, 1980, Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor, Eur. J. Cancer, 10, 1441, 10.1016/0014-2964(80)90053-5 · doi:10.1016/0014-2964(80)90053-5
- Manil, 1995, Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles, Pharm. Res., 12, 85, 10.1023/A:1016290704772 · doi:10.1023/a:1016290704772
- Blagoeva, 1992, Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles, Mutat. Res., 268, 77, 10.1016/0027-5107(92)90085-G · doi:10.1016/0027-5107(92)90085-g
- Sharma, 1996, Novel taxol® formulation: polyvinylpyrrolidone nanoparticles-encapsulated taxol® for drug delivery in cancer therapy, Oncol. Res., 8, 281
- Sakakura, 1992, Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles, Anti-Cancer Drugs, 3, 233, 10.1097/00001813-199206000-00005 · doi:10.1097/00001813-199206000-00005
- Hagiwara, 1997, Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer—a pilot study, Anti-Cancer Drugs, 8, 666, 10.1097/00001813-199708000-00004 · doi:10.1097/00001813-199708000-00004
- Schwab, 1994, Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice, Proc. Natl. Acad. Sci. USA, 91, 10460, 10.1073/pnas.91.22.10460 · doi:10.1073/pnas.91.22.10460
- Chavany, 1994, Adsorption of oligonucleotides onto poly(isohexylcyanoacrylate) nanoparticles protects them against nucleases and increases their cellular uptake, Pharm. Res., 11, 1370, 10.1023/A:1018923301967 · doi:10.1023/a:1018923301967
- Godard, 1995, Antisense effect of cholesterol–oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles, Eur. J. Biochem., 232, 404, 10.1111/j.1432-1033.1995.tb20825.x · doi:10.1111/j.1432-1033.1995.tb20825.x
- Tondelli, 1998, Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres, Nucleic Acids Res., 26, 5425, 10.1093/nar/26.23.5425 · doi:10.1093/nar/26.23.5425
- Zimmer, 1999, Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers, Methods: A Companion to Methods in Enzymology, 18, 286, 10.1006/meth.1999.0786 · doi:10.1006/meth.1999.0786
- Ganachaud, 1997, Adsorption of single-strand DNA fragments onto cationic aminated latex particles, Langmuir, 13, 701, 10.1021/la960896e · doi:10.1021/la960896e
- Hu, 1996, On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance, Cancer Chemother. Pharmacol., 37, 556, 10.1007/s002800050428 · doi:10.1007/s002800050428
- Astier, 1988, Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells, Cancer Res., 48, 1835
- Nafziger, 1995, Synthesis and antiproliferative effects of a 4′-morpholino-9-methyl anthracycline, J. Antibiot., 48, 1185, 10.7164/antibiotics.48.1185 · doi:10.7164/antibiotics.48.1185
- Leo, 1997, General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles, Il Farmaco, 52, 385
- Bhalgat, 1998, Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry, J. Immunol. Methods, 219, 57, 10.1016/S0022-1759(98)00121-5 · doi:10.1016/s0022-1759(98)00121-5
- Väisänen, 2000, Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies, Luminescence, 15, 389, 10.1002/1522-7243(200011/12)15:6<389::AID-BIO626>3.0.CO;2-7 · doi:10.1002/1522-7243(200011/12)15:6<389::aid-bio626>3.0.co;2-7
- Santra, 2001, Development of novel dye-doped silica nanoparticles for biomarker application, J. Biomed. Opt., 6, 160, 10.1117/1.1353590 · doi:10.1117/1.1353590
- Wisner, 1996, Indirected computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model, Acad. Radiol., 3, 40, 10.1016/S1076-6332(96)80331-X · doi:10.1016/s1076-6332(96)80331-x
- Wisner, 1996, Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles, Acad. Radiol., 3, S257, 10.1016/S1076-6332(96)80551-4 · doi:10.1016/s1076-6332(96)80551-4
- Clément, 1994, Magnetic resonance lymphography—Enhancement patterns using superparamagnetic nanoparticles, Invest. Radiol., 29, S226, 10.1097/00004424-199406001-00075 · doi:10.1097/00004424-199406001-00075
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Synthesis, characterization, applications, and challenges of iron oxide nanoparticles
Ali, A., Zafar, H., Zia, M., ul Haq, I., Phull, A. R., Ali, J. S., & Hussain, A. (2016) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s99986 · Cited by 1,591
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 855
Ratiometric optical nanoprobes enable accurate molecular detection and imaging
Huang, X., Song, J., Yung, B. C., Huang, X., Xiong, Y., & Chen, X. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00612h · Cited by 820
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 666
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Metal‐Organic Framework Nanoparticles in Photodynamic Therapy: Current Status and Perspectives
Lismont, M., Dreesen, L., & Wuttke, S. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606314 · Cited by 622
Molecularly Imprinted Polymers: Antibody Mimics for Bioimaging and Therapy
Haupt, K., Medina Rangel, P. X., & Bui, B. T. S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00428 · Cited by 561
Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
Zhong, Y., Meng, F., Deng, C., & Zhong, Z. (2014) · Biomacromolecules · doi:10.1021/bm5003009 · Cited by 541
Nanoparticles in tissue engineering: applications, challenges and prospects
Hasan, A., Morshed, M., Memic, A., Hassan, S., Webster, T., & Marei, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s153758 · Cited by 496
Nanomedicine in pulmonary delivery
Mansour, H., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 485
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Dong, S. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2824 · Cited by 464
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 453
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
Li, R., He, Y., Zhang, S., Qin, J., & Wang, J. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.009 · Cited by 430
Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy
Yang, K., Feng, L., & Liu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.015 · Cited by 415
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Yin, Q., Shen, J., Zhang, Z., Yu, H., & Li, Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.011 · Cited by 365
Cheng, Y.-H., He, C., Riviere, J. E., Monteiro-Riviere, N. A., & Lin, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b08142 · Cited by 362
Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery
Lu, B., Lv, X., & Le, Y. (2019) · Polymers · doi:10.3390/polym11020304 · Cited by 349
Antibacterial effect of silver nanoparticles in Pseudomonas aeruginosa
Salomoni, R., Léo, P., Montemor, A., Rinaldi, B., & Rodrigues, M. (2017) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s133415 · Cited by 334
Assessment of PEG on polymeric particles surface, a key step in drug carrier translation
Rabanel, J.-M., Hildgen, P., & Banquy, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.017 · Cited by 318
Synthesis and Biomedical Applications of Multifunctional Nanoparticles
Kim, D., Shin, K., Kwon, S. G., & Hyeon, T. (2018) · Advanced Materials · doi:10.1002/adma.201802309 · Cited by 317
Alginate Nanoparticles for Drug Delivery and Targeting
Severino, P., da Silva, C. F., Andrade, L. N., de Lima Oliveira, D., Campos, J., & Souto, E. B. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190425163424 · Cited by 304
Nanotechnological carriers for cancer chemotherapy: The state of the art
Estanqueiro, M., Amaral, M. H., Conceição, J., & Sousa Lobo, J. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.12.041 · Cited by 298
Yang, D., Yang, G., Yang, P., Lv, R., Gai, S., Li, C., He, F., & Lin, J. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700371 · Cited by 290
Recent Advances of Using Hybrid Nanocarriers in Remotely Controlled Therapeutic Delivery
Li, Z., Ye, E., David, Lakshminarayanan, R., & Loh, X. J. (2016) · Small · doi:10.1002/smll.201601129 · Cited by 277
Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles
Rodzinski, A., Guduru, R., Liang, P., Hadjikhani, A., Stewart, T., Stimphil, E., Runowicz, C., Cote, R., Altman, N., Datar, R., et al. (2016) · Scientific Reports · doi:10.1038/srep20867 · Cited by 271
Application of Nanotechnology in Drug Delivery
(2014) · InTech eBooks · doi:10.5772/57028 · Cited by 266
Polydopamine-Based Multifunctional (Nano)materials for Cancer Therapy
Mrówczyński, R. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08392 · Cited by 263
Ray Chowdhuri, A., Bhattacharya, D., & Sahu, S. K. (2016) · Dalton Transactions · doi:10.1039/c5dt03736k · Cited by 253
Banerjee, A., Pathak, S., Subramanium, V. D., G., D., Murugesan, R., & Verma, R. S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.006 · Cited by 204
Shen, J., Karges, J., Xiong, K., Chen, Y., Ji, L., & Chao, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120979 · Cited by 130
Riaz, S., Ali, S., Summer, M., Akhtar, U., Noor, S., Haqqi, R., Farooq, M. A., & Sardar, I. (2025) · Annals of Biomedical Engineering · doi:10.1007/s10439-025-03712-3 · Cited by 38
Freund, E., Miebach, L., Stope, M., & Bekeschus, S. (2021) · Oncology Reports · doi:10.3892/or.2021.8022 · Cited by 18
Surface functionalized magnetic nanoparticles for targeted cancer therapy and diagnosis
Saifullah, S., Ali, I., Kawish, M., El-Shabasy, R. M., Chen, L., & El-Seedi, H. R. (2020) · Metal Nanoparticles for Drug Delivery and Diagnostic Applications · doi:10.1016/b978-0-12-816960-5.00012-4 · Cited by 13
Nanoparticle-Incorporated Soy Protein Isolate Films
Rani, S., & Kumar, R. (2020) · Nanotechnology in the Life Sciences · doi:10.1007/978-3-030-31938-0_2 · Cited by 3
Metadata
- Authors
- Brigger, I., Dubernet, C., & Couvreur, P.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 64
- Pages
- 24-36
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4232680877
- Cited by
- 956
- References
- 72
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.